{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:52:44Z","timestamp":1794023564173,"version":"4.8.0"},"reference-count":27,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cochlear Limited, Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMAHP"],"abstract":"<jats:p>The aim of this study was to evaluate the comparative clinical effectiveness and cost-utility of the active transcutaneous Osia\u00ae System versus the passive transcutaneous Baha\u00ae Attract System for patients with conductive or mixed hearing loss or single-sided deafness in an Australian healthcare setting. In the absence of direct comparative evidence, an indirect treatment comparison (ITC) of the clinical effectiveness and utility gains was needed. The ITC was informed by three studies identified through a systematic literature review. A Markov model was developed to evaluate the cost-utility of the Osia System. The literature review identified three studies suitable to inform an ITC: Mylanus et al. 2020 and Briggs et al. 2022 (Osia System) and den Besten et al. 2019 (Baha Attract System). The Osia System was found to be clinically superior to the Baha Attract System, across objective audiological outcomes resulting in a clinically meaningful utility benefit of 0.03 measured by the Health Utility Index with at least equivalent safety. In conclusion, the Osia System is more effective than the Baha Attract System, providing better hearing and health-related quality of life outcomes. In an Australian healthcare setting, the Osia System is cost-effective as demonstrated in a cost-utility analysis versus the Baha Attract System.<\/jats:p>","DOI":"10.3390\/jmahp12010003","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:48:01Z","timestamp":1709704081000},"page":"5-20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7200-2458","authenticated-orcid":false,"given":"Matthias","family":"Brunner","sequence":"first","affiliation":[{"name":"Cochlear Limited, Macquarie University, Sydney, NSW 2109, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Schou","sequence":"additional","affiliation":[{"name":"Cochlear Limited, Macquarie University, Sydney, NSW 2109, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Briggs","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Otolaryngology, University of Melbourne, Parkville, VIC 3052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dell","family":"Kingsford Smith","sequence":"additional","affiliation":[{"name":"Cochlear Limited, Macquarie University, Sydney, NSW 2109, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/MAO.0000000000002794","article-title":"Multicenter Clinical Investigation of a New Active Osseointegrated Steady-State Implant System","volume":"41","author":"Mylanus","year":"2020","journal-title":"Otol. Neurotol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MAO.0000000000003590","article-title":"Clinical Performance, Safety, and Patient-Reported Outcomes of an Active Osseointegrated Steady-State Implant System","volume":"43","author":"Briggs","year":"2022","journal-title":"Otol. Neurotol."},{"key":"ref_3","first-page":"370","article-title":"Implantable hearing devices\u2014An update","volume":"45","year":"2016","journal-title":"Aust. J. Gen. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1055\/s-0042-1745734","article-title":"Assessment Protocol for Candidates for Bone-Anchored Hearing Devices","volume":"26","author":"Ueda","year":"2022","journal-title":"Int. Arch. Otorhinolaryngol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jfma.2019.01.013","article-title":"Simultaneous auricular reconstruction and transcutaneous bone conduction device implantation in patients with microtia","volume":"118","author":"Chan","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23753","DOI":"10.1073\/pnas.1903315116","article-title":"Extended high-frequency hearing enhances speech perception in noise","volume":"116","author":"Silbert","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Magele, A., Schoerg, P., Stanek, B., Gradl, B., and Sprinzl, G.M. (2019). Active transcutaneous bone conduction hearing implants: Systematic review and meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221484"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00106-020-00877-2","article-title":"Implantation of a new active bone conduction hearing device with optimized geometry","volume":"68","author":"Plontke","year":"2020","journal-title":"HNO"},{"key":"ref_9","unstructured":"Australian Government Department of Health and Aged Care (2020). Prosthesis List Guide 2020."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bjorl.2020.05.021","article-title":"The evaluation of a surgery and the short-term benefits of a new active bone conduction hearing implant\u2014The Osia\u00ae","volume":"88","author":"Gibasiewicz","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_11","unstructured":"PBAC (2016). Guidelines for Preparing a Submission to the Pharmaceutical Benefits Advisory Committee."},{"key":"ref_12","unstructured":"MSAC (2021). Guidelines for Preparing Assessments for the Medical Services Advisory Committee."},{"key":"ref_13","unstructured":"WHO (2019). Australian Life Tables."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3766\/jaaa.19.4.2","article-title":"Changes in hearing thresholds over 10 years in older adults","volume":"19","author":"Wiley","year":"2008","journal-title":"J. Am. Acad. Audiol."},{"key":"ref_15","unstructured":"Australian Government Department of Health and Aged Care (2022). Prostheses List."},{"key":"ref_16","unstructured":"Australian Government Department of Health and Aged Care (2022). Medicare Benefits Schedule."},{"key":"ref_17","unstructured":"Independent Health and Aged Care Pricing Authority (IHACPA) (2020). National Hospital Cost Data Collection (NHCDC) Public Hospitals Report\u2014Round 24 (Financial Year 2019\u201320) Appendix AR-DRG Version 10.0."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/coa.13248","article-title":"Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study","volume":"44","author":"Monksfield","year":"2019","journal-title":"Clin. Otolaryngol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MAO.0000000000002689","article-title":"Results of a 2-Year Prospective Multicenter Study Evaluating Long-term Audiological and Clinical Outcomes of a Transcutaneous Implant for Bone Conduction Hearing","volume":"41","author":"Kruyt","year":"2020","journal-title":"Otol. Neurotol."},{"key":"ref_20","unstructured":"(2022, February 14). Food and Drug Administration (FDA), Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K191921.pdf."},{"key":"ref_21","unstructured":"Food and Drug Administration (FDA) (2003). Implantable Middle Ear Hearing Device\u2014Guidance for Industry and FDA Staff."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/07853890109002088","article-title":"Introducing economic and quality of life measurements into clinical studies","volume":"33","author":"Drummond","year":"2001","journal-title":"Ann. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jval.2018.01.017","article-title":"Comparing the ICERs in Medicine Reimbursement Submissions to NICE and PBAC-Does the Presence of an Explicit Threshold Affect the ICER Proposed?","volume":"21","author":"Wang","year":"2018","journal-title":"Value Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(10)70065-7","article-title":"CRD\u2019s Guidance for Undertaking Reviews in Health Care","volume":"10","author":"Tacconelli","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000443629","article-title":"Mini Review of the Cost-Effectiveness of Unilateral Osseointegrated Implants in Adults: Possibly Cost-Effective for the Correct Indication","volume":"21","author":"Crowson","year":"2016","journal-title":"Audiol. Neurotol."},{"key":"ref_26","first-page":"1","article-title":"Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment","volume":"20","author":"Lee","year":"2020","journal-title":"Ont. Health Technol. Assess. Ser."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/coa.13659","article-title":"Longitudinal economic analysis of Bonebridge 601 versus percutaneous bone-anchored hearing devices over a 5-year follow-up period","volume":"46","author":"Amin","year":"2021","journal-title":"Clin. Otolaryngol."}],"container-title":["Journal of Market Access &amp; Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2001-6689\/12\/1\/3\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:09:44Z","timestamp":1760105384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2001-6689\/12\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["jmahp12010003"],"URL":"https:\/\/doi.org\/10.3390\/jmahp12010003","relation":{},"ISSN":["2001-6689"],"issn-type":[{"value":"2001-6689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]}}}